AU2002249221A1 - Use of casb7439 (ash2) in the immunotherapy of breast cancer - Google Patents

Use of casb7439 (ash2) in the immunotherapy of breast cancer

Info

Publication number
AU2002249221A1
AU2002249221A1 AU2002249221A AU2002249221A AU2002249221A1 AU 2002249221 A1 AU2002249221 A1 AU 2002249221A1 AU 2002249221 A AU2002249221 A AU 2002249221A AU 2002249221 A AU2002249221 A AU 2002249221A AU 2002249221 A1 AU2002249221 A1 AU 2002249221A1
Authority
AU
Australia
Prior art keywords
casb7439
ash2
immunotherapy
breast cancer
breast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002249221A
Inventor
Jean-Pol Cassart
Carlota Vinals Y De Bassols
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Publication of AU2002249221A1 publication Critical patent/AU2002249221A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU2002249221A 2001-02-21 2002-02-15 Use of casb7439 (ash2) in the immunotherapy of breast cancer Abandoned AU2002249221A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0104259.7A GB0104259D0 (en) 2001-02-21 2001-02-21 Novel compounds
GB0104259.7 2001-02-21
PCT/EP2002/001649 WO2002066506A2 (en) 2001-02-21 2002-02-15 Use of casb7439 (ash2) in the immunotherapy of breast cancer

Publications (1)

Publication Number Publication Date
AU2002249221A1 true AU2002249221A1 (en) 2002-09-04

Family

ID=9909202

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002249221A Abandoned AU2002249221A1 (en) 2001-02-21 2002-02-15 Use of casb7439 (ash2) in the immunotherapy of breast cancer

Country Status (3)

Country Link
AU (1) AU2002249221A1 (en)
GB (1) GB0104259D0 (en)
WO (1) WO2002066506A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0111974D0 (en) * 2001-05-16 2001-07-04 Glaxosmithkline Biolog Sa Novel Compounds
PE20120400A1 (en) * 2009-05-27 2012-05-04 Glaxosmithkline Biolog Sa CASB7439 CONSTRUCTIONS
US9579283B2 (en) * 2011-04-28 2017-02-28 Stc.Unm Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
GB201520592D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
WO2017120504A1 (en) 2016-01-08 2017-07-13 Durfee Paul N Osteotropic nanoparticles for prevention or treatment of bone metastases
US11344629B2 (en) 2017-03-01 2022-05-31 Charles Jeffrey Brinker Active targeting of cells by monosized protocells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5788900A (en) * 1999-07-07 2001-01-22 Tularik Inc. Diagnosis of cancer by detecting ash2 polypeptides or polynucleotides

Also Published As

Publication number Publication date
WO2002066506A3 (en) 2002-12-19
GB0104259D0 (en) 2001-04-11
WO2002066506A2 (en) 2002-08-29

Similar Documents

Publication Publication Date Title
AU2003222604A1 (en) Proteins involved in breast cancer
AU2002212527A1 (en) Thermometry-based breast cancer risk assessment
AU2002360769A1 (en) Breast cancer expression profiling
AU2002362454A1 (en) Regulated breast cancer genes
AUPR395801A0 (en) Antibodies against cancer
AU2002247304A1 (en) Anti-neovasculature preparations for cancer
AUPS054702A0 (en) Cancer therapy
AU2002311869A1 (en) Breast cancer-associated genes and uses thereof
AU2003212634A1 (en) Compounds useful in the treatment of cancer
AU2002220441A1 (en) Breast pump
AU2002364708A1 (en) Novel compositions and methods for cancer
AU2002349543A1 (en) Tumor antigens
GB0228900D0 (en) Cancer Immunotherapy
EP1496923A4 (en) Cancer immunotherapy
AU2002258597A1 (en) Prognostic methods for breast cancer
AU2002313726A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2002249221A1 (en) Use of casb7439 (ash2) in the immunotherapy of breast cancer
AU2001288921A1 (en) Human breast cancer biomarkers
AU2002337943A1 (en) Novel compositions and methods for cancer
AU2002253899A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2003283339A1 (en) Cancer therapy determination
AU2002360815A1 (en) Human breast cancer biomarkers
AU2003302625A1 (en) Silicon compounds useful in cancer therapy
AU2002354943A1 (en) Haptenizing cancer cell components for the preparation of cancer vaccines
AU2002363807A1 (en) Breast cancer associated polypeptide

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase